Healthcare Capital Corp/DE
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $200M
- Underwriters
- Focus
- Healthcare, Life Sciences, Technology
- SEC Filings
- 1822935
- Public Embarc Page
- https://embarc.com/capital/spac/1822935/HCCC/healthcare-capital-corpde
- IPO Ticker
- HCCC
SPAC Leadership
Information on the SPAC leadership.
- Chairman of the Board of DirectorsDavid Milch
- Chief Executive Officer and DirectorWilliam Johns
- Chief Financial OfficerPhilip A. Baseil
- DirectorThomas R. Insel
- DirectorPeter Kash
- DirectorBruce E. Roberts
Target Information
Information on the SPAC target for merger.
- Company
- Alpha Tau
- Presentation
- Investor Presentation (SEC) on 2022-01-12
- Description
- "Alpha Tau's proprietary Alpha DaRT is designed to deliver uniquely potent alpha radiation to destroy solid tumors with localized precision, sparing surrounding healthy tissue, thereby maintaining cancer patients' quality of life."